Showing results (431-440 of 1,585) with videos related to

Sort By:
Pageof 159
RSC Medicinal Chemistry|August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitorsAnmol Gulati, Charles S Yeung, Blair Lapointe, et al.
RSC Medicinal Chemistry|August 6, 2021
Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopramGisela Andrea Camacho-Hernandez, Andrea Casiraghi, Deborah Rudin, et al.
RSC Medicinal Chemistry|August 6, 2021
Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971Filomena Mattner, Andrew Katsifis, Thomas Bourdier, et al.
RSC Medicinal Chemistry|February 10, 2023
Antioxidant mechanisms and products of four 4',5,7-trihydroxyflavonoids with different structural typesBan Chen, Jiangtao Su, Yuchen Hu, et al.
RSC Medicinal Chemistry|February 10, 2023
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccineShiwei Su, Liqing Chen, Menglan Yang, et al.
RSC Medicinal Chemistry|September 12, 2022
Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranosticsKenji Mishiro, Mengfei Wang, Saki Hirata, et al.
RSC Medicinal Chemistry|September 12, 2022
Recent applications of covalent chemistries in protein-protein interaction inhibitorsAlexandria M Chan, Christopher C Goodis, Elie G Pommier, et al.
RSC Medicinal Chemistry|February 5, 2025
Discovery of a novel pyrimidine derivative for treatment of acute lung injury through reducing oxidative stress and inflammatory responseYu Jie Jian, Qi Lv, Leran Du, et al.
RSC Medicinal Chemistry|February 3, 2025
Design, synthesis, antimicrobial activity, stability, and mechanism of action of bioresorbable cerageninsShawn Gubler, Aaron Zaugg, Rebekah Yi, et al.
RSC Medicinal Chemistry|January 24, 2025
Nitroaromatic-based triazene prodrugs to target the hypoxic microenvironment in glioblastomaCláudia Braga, Margarida Ferreira-Silva, M Luísa Corvo, et al.
Pageof 159